Pharma is investing billions in AI, data, and digital transformation – but investment alone is not transformation.
Despite significant progress, commercial teams still face historic barriers: fragmented data, disconnected CRM, siloed internal teams, poor field adoption, and AI pilots that struggle to scale. These challenges continue to limit truly personalised HCP engagement and measurable commercial impact.
Now is the time to move from experimentation to execution. When data connects, marketing and commercial teams align, and technology simplifies engagement, pharma can build smarter, faster, and more scalable commercial capabilities.
Reuters Events: Pharma Commercial Data and Tech 2026 (4–5 November, London) shows you how.
Bringing together 250 senior leaders across commercial, customer engagement, data, digital, AI, and technology, this event unites the pioneers turning digital ambition into enterprise-wide impact, empowering the next era of customer engagement.
This Reuters event stands out from many other conferences for two key reasons; the incredibly talented speakers who give honest, insightful and relevant talks that I genuinely learned from; and the networking where I met some of the best agency and pharma contacts who I have now built great relationships with
With an impressive 87% of attendees holding director-level positions or above, this event is the one true home of the most influential decision-makers in the field. Whether it’s at networking drinks or during a coffee break, this event offers ample opportunity to connect with industry leaders and catalyse real, long-lasting change.
